Statement from Ralph G. Neas, President and CEO of the Generic Pharmaceutical Association on the Mutual v. Bartlett Supreme Court Ruling

Published Online: Monday, June 24, 2013
Follow Pharmacy_Times:
PRESS RELEASE

WASHINGTON, DC (June 24, 2013) — “Today’s Supreme Court ruling on the Mutual v. Bartlett case upholds a key principle: decisions about the safety and efficacy of prescription drugs should rest with scientific experts at the Food and Drug Administration (FDA).

When it comes to decisions on safety and approval of prescription medicine, the FDA is best equipped to make judgments that affect patients. The experts at FDA alone have the scientific knowledge, regulatory experience, and complete data to make these decisions.

The FDA’s job is to evaluate drugs on the science and make decisions that balance safety and risk with the need for access to life-saving medicines. Millions of patients rely on drugs like sulindac, which has been on the market for more than 30 years. It was prescribed and dispensed more than 300 million times between 2007-2012 with a typical safety profile. Decisions with this much at stake belong in the hands of the scientific, public health and regulatory experts at the FDA.

Related Articles
Many pharmacy students advocate for provider status, but how often do they engage in other political matters?
Today, an expert panel at the 2015 Generic Pharmaceutical Association Annual Meeting, “FDA and Industry Perspectives on Quality Culture,” convened to discuss a shared commitment with industry to the highest standards of manufacturing quality and regulatory processes.
The Generic Pharmaceutical Association today announced the election of its 2015 Executive Committee and Board of Directors.
The Generic Pharmaceutical Association and its members applaud the significant progress made by the agency during Commissioner of Food and Drugs Dr. Margaret Hamburg’s six years leading the U.S. Food and Drug Administration. Throughout her tenure, Dr. Hamburg has been a tireless advocate for patient safety and a leader in efforts to assure that FDA decisions are guided by scientific principles.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$